AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - NYSE:AMN - US0017441017 - Common Stock
19.26 USD
+0.25 (+1.32%)
19.26 USD
0 (0%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AMN while its profitability can be described as average. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
Of the past 5 years AMN 4 years were profitable.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
AMN has a Return On Assets of -13.46%. This is in the lower half of the industry: AMN underperforms 78.22% of its industry peers.
AMN has a worse Return On Equity (-49.02%) than 72.28% of its industry peers.
AMN has a Return On Invested Capital (2.66%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.19%.
The last Return On Invested Capital (2.66%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROIC | 2.66% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
The Operating Margin of AMN (2.12%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AMN has declined.
AMN has a Gross Margin of 29.84%. This is comparable to the rest of the industry: AMN outperforms 57.43% of its industry peers.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
Compared to 1 year ago, AMN has more shares outstanding
Compared to 5 years ago, AMN has less shares outstanding
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.37 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.37) which is comparable to the rest of the industry.
The Debt to FCF ratio of AMN is 3.59, which is a good value as it means it would take AMN, 3.59 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AMN (3.59) is better than 74.26% of its industry peers.
AMN has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AMN (1.51) is worse than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Altman-Z | 2.37 |
ROIC/WACC0.34
WACC7.77%
2.3 Liquidity
A Current Ratio of 1.00 indicates that AMN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.00, AMN is doing worse than 73.27% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that AMN may have some problems paying its short term obligations.
The Quick ratio of AMN (1.00) is worse than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -59.73% in the last year.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -14.33% in the last year.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-64.45%
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue Next Year-11.94%
Revenue Next 2Y-7.1%
Revenue Next 3Y-2.9%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.13, the valuation of AMN can be described as reasonable.
94.06% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.41. AMN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 16.86, AMN is valued correctly.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AMN to the average of the S&P500 Index (22.88), we can say AMN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 16.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.89 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -22.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)11.35
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.26
+0.25 (+1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.62%
Inst Owner Change-1.07%
Ins Owners0.42%
Ins Owner Change1.98%
Market Cap738.04M
Analysts69.23
Price Target20.4 (5.92%)
Short Float %6.74%
Short Ratio2.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.83%
Min EPS beat(2)53.64%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)56.81%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)34.9%
EPS beat(12)12
Avg EPS beat(12)26.31%
EPS beat(16)16
Avg EPS beat(16)23.47%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.84%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)-23.29%
PT rev (3m)-24.63%
EPS NQ rev (1m)-5.77%
EPS NQ rev (3m)-12.7%
EPS NY rev (1m)3.21%
EPS NY rev (3m)16.5%
Revenue NQ rev (1m)-0.74%
Revenue NQ rev (3m)-4.83%
Revenue NY rev (1m)-1.8%
Revenue NY rev (3m)-2.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 16.86 | ||
| P/S | 0.27 | ||
| P/FCF | 2.89 | ||
| P/OCF | 2.38 | ||
| P/B | 1.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.23 |
EPS(TTM)2.11
EY10.96%
EPS(NY)1.14
Fwd EY5.93%
FCF(TTM)6.67
FCFY34.62%
OCF(TTM)8.11
OCFY42.1%
SpS72.28
BVpS15.86
TBVpS-12.28
PEG (NY)N/A
PEG (5Y)11.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROCE | 3.58% | ||
| ROIC | 2.66% | ||
| ROICexc | 2.73% | ||
| ROICexgc | 8.39% | ||
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% | ||
| FCFM | 9.22% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 33.64% | ||
| Cap/Sales | 1.99% | ||
| Interest Coverage | 1.13 | ||
| Cash Conversion | 139.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.37 |
F-Score4
WACC7.77%
ROIC/WACC0.34
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
EPS Next Y-64.45%
EPS Next 2Y-41.25%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
Revenue Next Year-11.94%
Revenue Next 2Y-7.1%
Revenue Next 3Y-2.9%
Revenue Next 5Y4.4%
EBIT growth 1Y-70.44%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year93.69%
EBIT Next 3Y30.53%
EBIT Next 5YN/A
FCF growth 1Y-32.27%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%